Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Dr. David Yankelevitz on Evaluation and Management of Pulmonary Nodules
Author
Howard (Jack) West, MD

yankelevitz-lung-nodules-sample-figure Here's the podcast from the recent webinar by Dr. David Yankelevitz, Professor of Radiology at Mount Sinai Medical Center in New York City, on the subject of "Pulmonary Nodules: Evaluation and Management".  He took us through a wonderful review of many recent developments in CT scans, both in screening programs and informal workup of many other medical settings, as well as how the best radiologists distinguish higher from lower risk nodules.  He also covered the work-up of higher risk nodules with CT-guided biopsies.

One key point: a huge proportion of lung nodules aren't cancer, and as our CT scanners get more sensitive, we're going to be finding nodules in just about everyone.  But when they're that common, it's not really appropriate to call them abnormal.

Below is the audio and video versions of the podcast, as well as the transcript and figures:

[powerpress]

dr-yankelevitz-pulm-nodules-evaluation-and-management-audio-podcast

dr-yankelevitz-pulm-nodules-evaluation-and-management-transcript

dr-yankelevitz-pulm-nodules-evaluation-and-management-figures

This was another webinar in the terrific expert series that we developed in partnership with LUNGevity Foundation.  Thanks to both Dr. Yankelevitz and LUNGevity for making this great program possible.  I hope it's helpful.

Next Previous link

Previous PostNext Post

Related Content

Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on